Corcept Therapeutics Incorporated (NASDAQ:CORT) CEO Sells $3,314,400.00 in Stock
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) CEO Joseph K. Belanoff sold 40,000 shares of Corcept Therapeutics stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $82.86, for a total transaction of $3,314,400.00. Following the transaction, the chief executive officer now owns 2,901,985 shares of the […]
